Advent-Morro Equity Partners

Kiwi is a fintech dedicated to helping Latinos build credit history and improve financial literacy. Kiwi offers a credit card meant to keep people out of debt and in charge of their finances. Kiwi users can apply for a loan from $150 to $1,000. Users can complete their application through the app, and Kiwi will examine the information and contact them as soon as possible regarding their application. Everything is done entirely online, with no paperwork. Kiwi loans feature monthly installments ranging from 4 to 24 months, and users can pick between various payment methods.

Hyperion is an all-in-one finance app that integrates essential financial services for small businesses through a mobile application. Hyperion’s customers can validate a business in minutes, having access to cash management, B2B payments, financial reports, and a business network they can tap into.

Kiwi is a fintech dedicated to helping Latinos build credit history and improve financial literacy. Kiwi offers a credit card meant to keep people out of debt and in charge of their finances. Kiwi users can apply for a loan from $150 to $1,000. Users can complete their application through the app, and Kiwi will examine the information and contact them as soon as possible regarding their application. Everything is done entirely online, with no paperwork. Kiwi loans feature monthly installments ranging from 4 to 24 months, and users can pick between various payment methods.

Quench USA, Inc. offers Water-as-a-Service(TM) solutions by providing bottleless filtered water coolers and other products that use filtered water as an input, such as ice machines, sparkling water dispensers, and coffee brewers, to customers across the United States. Our point-of-use (POU) systems purify a building's existing water supply to provide reliable and convenient filtered water to a broad mix of end-markets, including government, education, medical, manufacturing, retail, hospitality, and other large commercial customers, including more than half of the Fortune 500. Headquartered outside of Philadelphia, Quench recently became an independent operating company of AquaVenture Holdings(TM).

Quench USA, Inc. offers Water-as-a-Service(TM) solutions by providing bottleless filtered water coolers and other products that use filtered water as an input, such as ice machines, sparkling water dispensers, and coffee brewers, to customers across the United States. Our point-of-use (POU) systems purify a building's existing water supply to provide reliable and convenient filtered water to a broad mix of end-markets, including government, education, medical, manufacturing, retail, hospitality, and other large commercial customers, including more than half of the Fortune 500. Headquartered outside of Philadelphia, Quench recently became an independent operating company of AquaVenture Holdings(TM).

Seven Seas Water Group is a multinational developer, focused on owning and operating decentralized water and wastewater treatment plants and businesses. Headquartered in Tampa and Houston, with operations across the U.S., Caribbean, and Latin America, Seven Seas delivers water and wastewater treatment solutions to governmental, municipal, industrial, and hospitality customers and owns more than 150 water and wastewater treatment plants. The Seven Seas Water-as-a-Service® model has been successfully deployed for over 20 years, demonstrating our leading capabilities with project execution, financing, risk management, and operations. In addition to building new plants, the company is actively acquiring existing water and wastewater treatment plant operations. In 2018, Seven Seas acquired Houston-based AUC Group, a leading provider of decentralized water and wastewater treatment plants throughout the U.S., with over 1,500 installations since 1970. Seven Seas is 100% owned by Morgan Stanley Infrastructure Partners and serves as their portfolio platform for investments in water and wastewater treatment companies.

AquaVenture Holdings is a water purification company that specializes in the service industry. Through its Quench and Seven Seas Water businesses, AVH provides water solutions, utilizing state-of-the-art purification and desalination technologies. It was founded in 2006 and headquartered in Tampa, Florida.

Bioheart, Inc. is dedicated to advancing the field of regenerative medicine by offering the highest quality technology, cellular treatments and training. Specific to biotechnology, Bioheart, Inc. specializes in the discovery, development and commercialization of autologous cellular therapies that treat a wide variety of degenerative diseases. Bioheart, Inc. is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry by delivering stem cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions, chronic and acute heart damage, peripheral vascular disease and other issues. Bioheart's goals are to improve a patient’s quality of life by regenerating their damaged tissue, when possible, and by reducing health care costs and hospitalizations. Bioheart’s leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.